Blue Water Vaccines enters ATM equity offering for up to $3.9M

Onconetix, Inc.

Entered ATM offering agreement with H.C. Wainwright to sell up to $3,900,000 of common stock.
Agent commission fixed at 3.0% of gross proceeds from each sale.
Shares sold at prevailing market prices on Nasdaq; no obligation to sell.
Issued under existing S-3 registration statement effective March 16, 2023.
Agreement may be terminated at any time by either party.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Onconetix, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at $3,900,000 (effective 2023-03-29).

Action: entry
Agreement: atm program
Counterparty: H.C. Wainwright & Co., LLC
Value: $3,900,000
Effective: 2023-03-29

Exact text from the filing

On March 29, 2023, Blue Water Vaccines Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (the “Agent”), to create an at-the-market equity program under which it may sell up to $3,900,000 of shares of the Company’s common stock (the “Shares”) from time to time through the Agent (the “ATM Offering”).

View on SEC.gov

Browse all material agreements →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-024177

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.